Home Categories API Minocycline hydrochloride
A5368212

Minocycline hydrochloride , 98% , 13614-98-7

Synonym(s):
7-Dimethylamino-6-demethyl-6-deoxytetracycline, HCl;Minocycline hydrochloride;Minocycline, Hydrochloride - CAS 13614-98-7 - Calbiochem;Minomycin

CAS NO.:13614-98-7

Empirical Formula: C23H28ClN3O7

Molecular Weight: 493.94

MDL number: MFCD00083669

EINECS: 237-099-7

Pack Size Price Stock Quantity
250MG RMB35.20 In Stock
1G RMB80.00 In Stock
5G RMB292.00 In Stock
25g RMB1015.20 In Stock
100g RMB3538.40 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 205-210° (dec)
Boiling point: 813℃
Flash point: >110°(230°F)
storage temp.  2-8°C
solubility  Sparingly soluble in water, slightly soluble in ethanol (96 per cent). It dissolves in solutions of alkali hydroxides and carbonates.
form  crystalline
color  yellow
Water Solubility  Freely soluble in water
Merck  14,6202
Stability: Light Sensitive
InChIKey GLMUAFMGXXHGLU-VQAITOIOSA-N
SMILES [C@@]12([H])C[C@@]3([H])C(C(=O)C4C(O)=CC=C(N(C)C)C=4C3)=C(O)[C@]1(O)C(=O)C(C(=O)N)=C(O)[C@H]2N(C)C.Cl |&1:0,3,21,31,r|
LogP 0.808 (est)
CAS DataBase Reference 13614-98-7(CAS DataBase Reference)

Description and Uses

Minocycline HCl (13614-98-7) displays antiapoptotic, anti-inflammatory1 activity. Prevents neuropathic pain in a rat sciatic nerve injury model.1 Reduces MMP-9 activity.2 Attenuates disease severity in mouse models of multiple sclerosis.3 Displays neuroprotective activity.4 Minocycline HCl may be effective in methotrexate-induced lung fibrosis.5?Orally active and brain penetrant.

antiinflammatory

Safety

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H317-H360-H362-H303-H315-H319-H335
Precautionary statements  P201-P202-P260-P263-P264-P270-P272-P280-P302+P352+P333+P313+P363-P308+P313-P405-P501-P261-P280a-P304+P340-P305+P351+P338-P501a
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36
RIDADR  3249
WGK Germany  3
RTECS  QI7630500
HazardClass  6.1(b)
PackingGroup  III
HS Code  29413020
Toxicity human,TDLo,oral,14286ug/kg/10 (14.286mg/kg),LUNGS, THORAX, OR RESPIRATION: RESPIRATORY OBSTRUCTIONLUNGS, THORAX, OR RESPIRATION: DYSPNEASKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE",Archives of Internal Medicine. Vol. 154, Pg. 1633, 1994.

RELATED PRODUCTS